Access: Novartis Gives It Away

Basel, Switzerland -Novartis plans to provide its malaria drug, Coartem (artemether/lumefantrin), at cost to developing countries in partnership with the World Health Organization (WHO). The effort is only the latest in a series of moves intended to increase access to essential medicines after Big Pharma’s South Africa debacle.

Related Content:

Pharmaceutical Executive-07-01-2001

Amgen's New Dream Team

Pharmacies: OTC Price Wars

One Disease at a Time